CClinicalTrials.gg
CompletedNCT02660632Updated Jun 8, 2018

Epidural Block vs. Rectus Sheath Block on Postoperative Pulmonary Function

An interventional study of Thoracic epidural analgesia (TEA) and Rectus sheath catheter block in Abdominal Surgeries, sponsored by Mansoura University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2018-06-08.

Sponsored by Mansoura University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Pulmonary complications are among the most important postoperative complications after midline incisions, for which different analgesic modalities have been tried.

Epidural analgesia is the recommended technique to relieve pain after major abdominal surgery owing to the proved superior analgesia, reduction of opioid related side effects as nausea, vomiting, pruritis and sedation, earlier recovery of bowel function and earlier ability for postoperative mobility However, it is not without complications.

Rectus sheath block provides several advantages over epidural anesthesia. It lessens the potential risks associated with neuraxial techniques, so it may represent a novel alternative approach for somatic analgesia after major abdominal surgeries. Although patients with rectus sheath block may experience some visceral pain, it is usually minimal by 24 hours after surgery.

Read the detailed description

The aim of this study is to compare the effects of thoracic epidural analgesia and rectus sheath blockade on postoperative pulmonary functions, pain scores, duration of analgesia, sedation scores, patients' satisfaction and adverse effects.

FEV1, FEV1/FVC ratio will be measured by a bed side spirometer.

  • Induction of anesthesia: propofol 1.5-2.5 mg kg-1.
  • Muscle Relaxants: rocuronium 0.6 mg kg-1 for induction.
  • Maintenance: Sevoflurane 0.7-1.5 MAC vaporized in air-oxygen (40% inspired fraction).

Radial artery catheterization: under complete aseptic conditions 20G cannula will be inserted into the radial artery of non-dominant hand after performing modified Allen's test and local infiltration of 0.5ml xylocaine 2% .

Thoracic epidural catheter will be inserted before induction of general anaesthesia under aseptic insertion conditions and using loss of resistance to air technique with the patient in the sitting position at T9- T11 interspaces.

The Rectus sheath catheters will be inserted bilaterally using ultrasound (SonoSite M-Turbo®, Sonosite , USA) guidance as described by Webster after induction of general anaesthesia.

02

Conditions studied

  • Abdominal Surgeries
03

In context

Lead sponsor

Mansoura University is the lead sponsor of 1,077 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • American Society of Anesthesiologists physical class I to III.
  • Patients scheduled for elective midline laparotomy.

Exclusion criteria

Exclusion Criteria:

  • Morbid obese patients.
  • Severe or uncompensated cardiovascular disease.
  • Significant renal disease.
  • Significant hepatic disease.
  • Pregnancy.
  • Lactating.
  • Allergy to the study medications.
  • Psychological disorder.
  • Neurological disorder.
  • Communication barrier.
  • Mental disorders.
  • Epilepsy.
  • FEV1 or FEV1/FVC ratio less than 50%, dyspnea with a New York Heart Association class IV.
  • Drug or alcohol abuse.
  • Contraindications to epidural anaesthesia.
  • Opioid analgesic medication within 24 h before the operation.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
100 participants (actual)

Study arms

  • Placebo comparator
    Thoracic epidural analgesia (TEA)

    Patients who will be subjected for midline laparotomy, will receive epidural analgesia through an inserted thoracic epidural catheter before induction of general anesthesia

    Other: Thoracic epidural analgesia (TEA)

  • Active comparator
    Rectus sheath catheter block

    After insertion of bilateral rectus sheath catheters, 20 ml of 0.25% bupivacaine will be injected on each side, then continuous infusion pumps will be connected to the catheters and set to deliver boluses of 20 mL of 0.25% bupivacaine, with a 4-hour lockout for up to 48 h postoperatively.

    Other: Rectus sheath catheter block

Interventions

  • OtherThoracic epidural analgesia (TEA)

    Epidural catheter will be inserted at T9-T11. Then, epidural analgesia will be activated with administering bolus of 10 mls 0.25% bupivacaine in conjunction with100 mcg fentanyl to establish a block. This will be followed by an infusion of 0.125% bupivacaine in conjunction with 2 mcg/ ml fentanyl at a rate of 10 mls /hour and then titrated to effect for up to 48 hour postoperative

  • OtherRectus sheath catheter block

    Following insertion of bilateral rectus sheath catheters, 20 ml of 0.25% bupivacaine will be injected through each one. Then continuous infusion pumps will be connected to the catheters and set to deliver boluses of 20 mL of 0.25% bupivacaine, with a 4-hour lockout for up to 48 h postoperatively.

06

What researchers measure

Primary outcomes

  1. Changes in forced expiratory volume in 1 second (FEV1)

    Time frame: Before and for 72 hours after surgery

  2. Changes in ratio between forced expiratory volume in 1 s and forced vital capacity (FEV1/FVC)

    Time frame: Before and for 72 hours after surgery

Secondary outcomes

  1. Changes in arterial blood gases

    Time frame: Before and for 72 hours after surgery

  2. Visual analog pain scores

    Postoperative pain will be assessed on rest and with cough and during movements for both of visceral and parietal pain

    Time frame: for 48 hours after surgery

  3. Sedation score

    Sedation scores using a sedation scale (awake and alert= 0; quietly awake= 1; asleep but easily roused= 2; deep sleep= 3.

    Time frame: for 48 hours after surgery

  4. Postoperative nausea and vomiting

    The degree of nausea and vomiting. Nausea will be measured using a numerical rating system (none= 0; mild= 1; moderate= 2; severe= 3). The number of vomiting episodes and the number of anti-emetics received

    Time frame: for 48 hours after surgery

  5. Return of bowel function

    The times to first flatus, defecation, intake of clear liquid and solid food tolerance

    Time frame: for 72 hours after surgery

  6. Time to hospital discharge

    from the end of anesthesia

    Time frame: for 15 days after surgery

  7. Cumulative tramadol use

    Time frame: For 48 hours after surgery

  8. Overall patient's satisfaction

    Patient overall satisfaction will be assessed before hospital discharge using the visual analog score

    Time frame: For 48 hours after surgery

  9. Intraoperative use of ephedrine

    Time frame: For 5 hours after induction of anesthesia

  10. Postoperative cardio-respiratory complications

    Time frame: For 7 days after surgery

  11. Postoperative wound infection

    Time frame: For 21 days after surgery

07

Study locations

1 site
  • Mansoura university
    Mansourah, DK 050, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 8, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02660632
Lead sponsor
Mansoura University
Responsible party
Sponsor
First posted
Jan 21, 2016
Start date
Jan 2017
Primary completion
May 2018
Completion
May 2018
Last update
Jun 8, 2018

Study contacts

Samah Elkenany, MD
principal investigator · Lecturer of Anesthesia and Surgical Intensive Care

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion